Tetramethylpyrazine-derived Polyurethane for Improved Hemocompatibility and Rapid Endothelialization

Baoliu Qu,Zhenzhen Hu,Weilong Tan,Bingyan Li,Yue Xin,Jinpeng Mo,Meilin Huang,Qinghua Wu,Yangling Li,Yingzhu Wu
DOI: https://doi.org/10.1039/d4tb01478b
IF: 7.571
2024-10-13
Journal of Materials Chemistry B
Abstract:Thrombus and intimal hyperplasia (IH) are the main factors affecting the long-term patency of small-diameter vascular grafts (SDVG). Fabricating confluent endothelial cells (ECs) layer on surfaces with physiological elasticity to mimic vascular endothelium should be an effective strategy to prevent restenosis that caused by Thrombus and IH. However, the vascular endothelialization process is time-consuming and always constrained by hemocompatibility of the vascular grafts, since excellent hemocompatibility could guarantee sufficient time window for the endothelialization process. Tetramethylpyrazine(TMP)-derived polyurethane(PU) with improving hemocompatibility and accelerating endothelialization is synthesized by incorporating TMP moieties in PU backbones. Results show the TMP-contained PU films possess improved hemocompatibility by down-regulating platelets adhesion and activation. Further, in vitro Human umbilical vein endothelial cells (HUVECs) test demonstrate that the introduction of TMP can significantly promote HUVECs adhesion and proliferation, and thus accelerating luminal endothelialization of vascular grafts. Moreover, the TMP-contained PU films exhibite excellent biocompatibility especially for HUVECs, and its excellent, adjustable elasticity (1123%) guarantees compliance accommodation of vascular grafts. This newly synthesized TMP-contained materials with multi-biological functions is expected to make up for the shortcomings of available SDVG in clinical practice, and has significant potential in improving the long-term patency of SDVG.
materials science, biomaterials
What problem does this paper attempt to address?